Valens (company)

THE VALENS COMPANY OBTAINS FINAL COURT ORDER APPROVING THE PROPOSED PLAN OF ARRANGEMENT WITH SNDL

Retrieved on: 
Tuesday, January 3, 2023
Valens (company), SEDAR, Wine, EDGAR, Ontario Superior Court of Justice, Arrangement, Green Road railway station, The Arrangement, Canada Business Corporations Act, Health, Partnership, Centre of Excellence for Biosecurity Risk Analysis, TSX, Growth, COVID-19, Risk, CBD, Private sector, Multimedia, Proxy, Cannabis, Research, Investment, Security (finance), Drug, Risk management, Valens

Under the terms of the Arrangement, Valens' shareholders will receive, for each common share of Valens (each, a "Valens Share"), 0.3334 of a common share of SNDL (the "Offer Exchange Ratio").

Key Points: 
  • Under the terms of the Arrangement, Valens' shareholders will receive, for each common share of Valens (each, a "Valens Share"), 0.3334 of a common share of SNDL (the "Offer Exchange Ratio").
  • The Valens Company is a leading cannabis consumer products company, with significant expertise in manufacturing cannabinoid-based products and a mission to bring the benefits of cannabis to the world.
  • Specific forward-looking statements include, without limitation, statements regarding the anticipated timing for completion of the proposed plan of arrangement involving The Valens Company and SNDL.
  • The risks and uncertainties that may affect forward-looking statements include, among others, if and when the proposed plan of arrangement involving The Valens Company and SNDL.

The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Retrieved on: 
Tuesday, December 13, 2022
BID, Toronto Stock Exchange, Calendar, Green Road station, Letter, Partnership, Valens (company), Panel, Research, Dr. João Havelange Centre of Excellence, CBD, COVID-19, Growth, Multimedia, Cannabis, TSX, Health, Acquisition, Risk, Auction, Security (finance), Risk management, Valens

As a result of the extension, the Company now has until June 12, 2023, to regain compliance with the Bid Price Requirement.

Key Points: 
  • As a result of the extension, the Company now has until June 12, 2023, to regain compliance with the Bid Price Requirement.
  • If the Company chooses to implement a share consolidation to regain compliance, it must complete the consolidation no later than ten business days prior to the expiration of the additional 180 calendar day period in order to timely regain compliance.
  • If the Company does not regain compliance with the Bid Price Requirement by June 12, 2023, Nasdaq will provide written notification to the Company that its shares will be subject to delisting.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

Microchip Technology to Present at the Raymond James Technology Investor Conference

Retrieved on: 
Thursday, December 1, 2022
Microchip Technology, Eastern Time Zone, Conference, Integrated circuit, Senior, Valens (company), Risk, Mobile phone

CHANDLER, Arizona, Dec. 01, 2022 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the Raymond James Technology Investor Conference on Tuesday, December 6 at 8:35 a.m. (Eastern Time).

Key Points: 
  • CHANDLER, Arizona, Dec. 01, 2022 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the Raymond James Technology Investor Conference on Tuesday, December 6 at 8:35 a.m. (Eastern Time).
  • A live webcast of the presentation will be made available by Raymond James, and can be accessed on the Microchip website at www.microchip.com .
  • Microchip Technology Incorporated is a leading provider of smart, connected and secure embedded control solutions.
  • Note: The Microchip name and logo are registered trademarks of Microchip Technology Inc. in the USA and other countries.

Microchip Technology to Present at the UBS Annual Global TMT Conference

Retrieved on: 
Thursday, December 1, 2022
Microchip Technology, Eastern Time Zone, Conference, Integrated circuit, Senior, UBS, Valens (company), Risk, Mobile phone

CHANDLER, Arizona, Dec. 01, 2022 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the UBS Annual Global TMT Conference on Monday, December 5 at 10:00 a.m. (Eastern Time).

Key Points: 
  • CHANDLER, Arizona, Dec. 01, 2022 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the UBS Annual Global TMT Conference on Monday, December 5 at 10:00 a.m. (Eastern Time).
  • A live webcast of the presentation will be made available by UBS, and can be accessed on the Microchip website at www.microchip.com .
  • Microchip Technology Incorporated is a leading provider of smart, connected and secure embedded control solutions.
  • Note: The Microchip name and logo are registered trademarks of Microchip Technology Inc. in the USA and other countries.

Valens Shareholders Vote in Favour of the Arrangement with SNDL

Retrieved on: 
Tuesday, November 29, 2022
COVID-19, Ethanol, Valens (company), Multimedia, Health Canada, Risk, ISO 17025, Biomass, Legislation, Cannabis, Ontario Superior Court of Justice, Drink, GMP, News, Center of excellence, Agreement, Thermo Fisher Scientific, CO2, ISO, Security (finance), Pharmaceutical industry, Arrangement, EU

The Valens Company is a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products.

Key Points: 
  • The Valens Company is a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products.
  • The forward-looking information included in this news release is made as of the date of this news release.
  • Valens does not undertake an obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise, except as required by applicable law.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/valens-shareholders-vote-in-fav...
    SOURCE The Valens Company Inc.

Microchip Technology to Present at the Credit Suisse 26th Annual Technology Conference

Retrieved on: 
Monday, November 28, 2022
Integrated circuit, Conference, Risk, Pacific Ocean, Microchip Technology, Pacific Time Zone, Valens (company), Credit Suisse, Credit, Mobile phone

CHANDLER, Ariz., Nov. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the Credit Suisse 26th Annual Technology Conference on Wednesday, September 14 at 9:15 a.m. (Pacific Time).

Key Points: 
  • CHANDLER, Ariz., Nov. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the Credit Suisse 26th Annual Technology Conference on Wednesday, September 14 at 9:15 a.m. (Pacific Time).
  • A live webcast of the presentation will be made available by Credit Suisse, and can be accessed on the Microchip website at www.microchip.com .
  • Microchip Technology Incorporated is a leading provider of smart, connected and secure embedded control solutions.
  • Note: The Microchip name and logo are registered trademarks of Microchip Technology Inc. in the USA and other countries.

AgriCann Solutions Provides Update to Shareholders

Retrieved on: 
Tuesday, November 22, 2022
Transfer, Soil, VPC, IP, CFO, CNC, Genetics, Valens (company), Condition, Health Canada, Conditional cash transfer, LOI, News, Treasury, Letter, AMS, Okanagan, RAM, Property management

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2022) - AgriCann Solutions Corp. (the "Company" or "AgriCann") is pleased to provide the following updates to shareholders.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - November 22, 2022) - AgriCann Solutions Corp. (the "Company" or "AgriCann") is pleased to provide the following updates to shareholders.
  • In accordance with the LOI, AgriCann added Tim Tombe, the owner of AMS, as Chief Operating Officer and a director.
  • AgriCann Solutions Corp. is a "Reporting Issuer" created as a result of a statutory plan of arrangement completed by The Valens Company in 2015.
  • The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by applicable law.

Valens Secures Sales Licence for Greater Toronto Area Beverage Facility

Retrieved on: 
Wednesday, November 2, 2022
Columbia, Growth, Valens (company), Cannabis, Centre of Excellence for Biosecurity Risk Analysis, Health, CBD, Partnership, Research, Intention, Risk, COVID-19, Center, TSX, Health Canada, NASDAQ, Compliance, Greater Toronto Area, GTA, The Green Road (Enright novel), Multimedia, Forward-looking statement, Drug, Risk management, Nasdaq, Valens, BC

KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors.

Key Points: 
  • KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors.
  • Prior to this announcement, Valens leveraged its British Columbia sales licence to sell into the provincial distributors which created additional cost and complexity in our supply chain.
  • "Since the opening of our facility in November 2021 we have already seen an increase in our beverage margins," said Tyler Robson, Chief Executive Officer of Valens.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

The Valens Company Reports Third Quarter Fiscal 2022 Financial Results

Retrieved on: 
Thursday, October 13, 2022
CBD, Cannabis, Risk, IFRS, Financial statement, Growth, Valens (company), Rationalization, Centre of Excellence for Operations in Confined and Shallow Waters, Transaction, Green Road station, Biomass, Research, Corporation, Multimedia, Depreciation, Conversation, Partnership, Center, Company, Acquisition, Health, Adult, Intention, Management, EBITDA, Operational definition, Forward-looking statement, COVID-19, Solution, Compliance, SEDAR, Drug, Risk management, Valens, Nasdaq, Analysis

See reconciliation of "Adjusted Gross Profit (non-GAAP measure)" in the Company's Management's Discussion and Analysis for the quarter ended August 31, 2022.

Key Points: 
  • See reconciliation of "Adjusted Gross Profit (non-GAAP measure)" in the Company's Management's Discussion and Analysis for the quarter ended August 31, 2022.
  • Subsequent to the quarter, Coldhaus launched in Ontario and British Columbia in September 2022 and in Alberta in October 2022.
  • In light of the proposed acquisition of the Company by SNDL, Valens is withdrawing all previously given financial guidance as such financial guidance is no longer appropriate under the circumstances.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

The Valens Company to Release Financial Results for the Third Quarter of 2022

Retrieved on: 
Thursday, October 6, 2022
Valens, CBD, Cannabis, Risk, Growth, Valens (company), TSX, Centre of Excellence for Biosecurity Risk Analysis, Green Road railway station, Research, Multimedia, Partnership, Center, Company, Health, Intention, Forward-looking statement, COVID-19, Compliance, Risk management, BC, Nasdaq

KELOWNA, BC, Oct. 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens") a leading manufacturer of cannabis products, is pleased to announce it will issue its third quarter 2022 financial results for the period ended August 31, 2022, on Thursday, October 13, 2022, before market open.

Key Points: 
  • KELOWNA, BC, Oct. 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens") a leading manufacturer of cannabis products, is pleased to announce it will issue its third quarter 2022 financial results for the period ended August 31, 2022, on Thursday, October 13, 2022, before market open.
  • The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world.
  • The Company provides proprietary cannabis processing services, in addition to best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.